Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1394-404.
Quality of life as a survival predictor for esophageal squamous cell
carcinoma treated with radiotherapy.
Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY,
Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital,
Kaohsiung Hsien, Taiwan. a7323630@ms14.hinet.net
J Clin Oncol. 2005 Jan 1;23(1):175-83.
Clinical model to predict survival in chemonaive patients with advanced
non-small-cell lung cancer treated with third-generation chemotherapy
regimens based on eastern cooperative oncology group data.
Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH,
University of Wisconsin Medical School, 600 Highland Ave, K4/562, Madison,
WI, USA. txh@medicine.wisc.edu
J Urol. 2005 May;173(5):1496-501.
Using tumor markers to predict the survival of patients with metastatic
renal cell carcinoma.
Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA,
Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo,
New York, USA.